Shanghai Kehua Bio-engineering Co Ltd Class A 002022
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 7.22
- Day Range
- CNY 7.20–7.32
- 52-Week Range
- CNY 6.19–11.85
- Bid/Ask
- CNY 7.24 / CNY 7.25
- Market Cap
- CNY 3.72 Bil
- Volume/Avg
- 2.5 Mil / 6.1 Mil
Key Statistics
- Price/Earnings (Normalized)
- 4.34
- Price/Sales
- 1.86
- Dividend Yield (Trailing)
- 8.31%
- Dividend Yield (Forward)
- —
- Total Yield
- 8.31%
Company Profile
Shanghai Kehua Bio-engineering Co Ltd is a developer, manufacturer, and marketer of in-vitro diagnostics business in China. Its products are mainly offered in two primary business segments: Diagnostic Reagents and Diagnostic Laboratory Instruments. Its products include diagnostic reagents, such as enzyme-immunoassay kits, clinical chemistry reagents, PCR kits, and rapid test kits and lab-instruments comprising chemistry analyzers, microplate washers/readers, electrolyte analyzers, and nucleic acid extractors.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 2,151
- Website
- http://www.skhb.com
Comparables
Valuation
|
Metric
|
002022
|
300463
|
301060
|
|---|---|---|---|
Price/Earnings (Normalized) | 4.34 | 25.40 | 31.72 |
Price/Book Value | 0.93 | 1.27 | 2.31 |
Price/Sales | 1.86 | 2.89 | 2.41 |
Price/Cash Flow | — | 11.07 | 9.18 |
Price/Earnings
002022
300463
301060
Financial Strength
|
Metric
|
002022
|
300463
|
301060
|
|---|---|---|---|
Quick Ratio | 3.45 | — | 2.50 |
Current Ratio | 4.78 | — | 3.03 |
Interest Coverage | −3.95 | — | −18.88 |
Quick Ratio
002022
300463
301060
Profitability
|
Metric
|
002022
|
300463
|
301060
|
|---|---|---|---|
Return on Assets (Normalized) | −5.11% | 4.64% | −5.18% |
Return on Equity (Normalized) | −8.33% | 6.05% | −8.53% |
Return on Invested Capital (Normalized) | −5.79% | 5.41% | −6.57% |
Return on Assets
002022
300463
301060
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Lgqmbbxj | Xmvnlz | $182.3 Bil | |
SYK
| Stryker Corp | Kxkbpwglwc | Txy | $126.5 Bil | |
MDT
| Medtronic PLC | Hhrmcjkgk | Frtyqrm | $111.9 Bil | |
BSX
| Boston Scientific Corp | Bxqrxlpw | Dqbgtp | $108.0 Bil | |
EW
| Edwards Lifesciences Corp | Pwhcjfvld | Yxvdsm | $54.3 Bil | |
DXCM
| DexCom Inc | Mclvxzth | Cnysg | $49.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Fmfbvphz | Cyykvk | $25.6 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Ydgdzvzvn | Pfc | $24.7 Bil | |
ALGN
| Align Technology Inc | Pjqcqvng | Xxrhcv | $21.1 Bil | |
PODD
| Insulet Corp | Kmwtwmqr | Mkdtwn | $11.3 Bil |